Lindsay M. Saunders, BS

Graduate Student

Lindsay M. Saunders, BS

Graduate Student

Lab Phone

646-888-2796

E-mail

saundel1@sloankettering.edu

Education

University of Michigan Ann Arbor

Mentor

Ross L. Levine

Publications

Dawson, M., Bannister, A., Saunders, L., Wahab, O., Liu, F., Nimer, S., Levine, R., Göttgens, B., Kouzarides, T., Green, A. (2011) Nuclear JAK2. Blood, 118, 6987-6988. PMID: 22194397.

Dey, A., Seshasayee, D., Noubade, R., French, D., Liu, J., Chaurushiya, M., Kirkpatrick, D., Pham, V., Lill, J., Bakalarski, C., Wu, J., Phu, L., Katavolos, P., LaFave, L., Abdel-Wahab, O., Modrusan, Z., Seshagiri, S., Dong, K., Lin, Z., Balazs, M., Suriben, R., Newton, K., Hymowitz, S., Garcia-Manero, G., Martin, F., Levine, R., Dixit, V. (2012) Loss of the tumor suppressor BAP1 causes myeloid transformation. Science, 337, 1541-1546. PMID: 22878500.

Koppikar, P., Bhagwat, N., Kilpivaara, O., Manshouri, T., Adli, M., Hricik, T., Liu, F., Saunders, L., Mullally, A., Abdel-Wahab, O., Leung, L., Weinstein, A., Marubayashi, S., Goel, A., Gönen, M., Estrov, Z., Ebert, B., Chiosis, G., Nimer, S., Berstein, B., Verstovsek, S., Levine, R. (2012) Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature, 489, 155-159. PMID: 22820254; PMCID: PMC3991463.

Abdel-Wahab, O., Adli, M., LaFave, L., Gao, J., Hricik, T., Shih, A., Pandey, S., Patel, J., Chung, Y., Koche, R., Perna, F., Zhao, X., Taylor, J., Park, C., Carroll, M., Melnick, A., Nimer, S., Jaffe, J., Aifantis, I., Bernstein, B., Levine, R. (2012) ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell, 22, 180-193. PMID: 22897849; PMCID: PMC3422511.

LaFave, L., Levine, R. (2012) JAK2 the future: therapeutic strategies for JAK-dependent malignancies. Trends Pharmacol Sci, 33, 574-582. PMID: 22995223.

LaFave, L., Levine, R. (2013) Mining the epigenetic landscape in ALL. Nat Genet, 45, 1269-1270. PMID: 24165727.

Abdel-Wahab, O., Gao, J., Adli, M., Dey, A., Trimarchi, T., Chung, Y., Kuscu, C., Hricik, T., Ndiaye-Lobry, D., LaFave, L., Koche, R., Shih, A., Guryanova, O., Kim, E., Li, S., Pandey, S., Shin, J., Telis, L., Liu, J., Bhatt, P., Monette, S., Zhao, X., Mason, C., Park, C., Bernstein, B., Aifantis, I., Levine, R. (2013) Deletion of Asxl1 results in myelodysplasia and sever developmental defects in vivo. J Exp Med, 210, 2641-2659. PMID: 24218140; PMCID: PMC3832937.

My Events